Abbie Celniker, President and CEO at Eleven Biotherapeutics, Inc. (EBIO), sold 10,029 shares at $2.08 ($21K) on 2016-06-27, disclosed to the SEC on 2016-06-29.
Open-market sale of $21k EBIO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |